Gen-Probe (Nasdaq: GPRO) has agreed to extend and expand its blood screening collaboration with Chiron, a Novartis (NYSE: NVS) business ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE